Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1255 studies found for:    Open Studies | "Virus Diseases"
Show Display Options
Rank Status Study
21 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
22 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
23 Recruiting Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV MEDI ΔM2-2 vaccine;   Biological: Placebo vaccine
24 Recruiting Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection
Condition: Hepatitis C Virus
Interventions: Drug: Simeprevir 150 mg;   Drug: Daclatasvir 60 mg;   Drug: Sofosbuvir 400 mg
25 Unknown  Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatitis B Virus;   Recurrence
Interventions: Drug: antiviral treatment (lamivudine or entecavir);   Procedure: radical resection of HBV-related HCC
26 Recruiting Respiratory Viral Infections in Pediatric Transplantation
Conditions: Infection in Solid Organ Transplant Recipients;   Complications of Organ Transplant;   Respiratory Viral Infection
Intervention:
27 Recruiting A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Cancer;   Epstein Barr Virus Infections
Intervention: Drug: MVA-EBNA1/LMP2 vaccine
28 Recruiting Phase II of Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
Conditions: Epstein Barr Virus Associated Non Hodgkin's Lymphoma;   Epstein Barr Virus Associated Hodgkin's Lymphoma;   Post-Transplant Lymphoproliferative Disease
Interventions: Drug: Doxorubicin;   Drug: Methotrexate;   Drug: Leucovorin;   Biological: Hydroxyurea;   Drug: Zidovudine;   Procedure: Urine Alkalization
29 Recruiting A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 With Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Conditions: Chronic Hepatitis C;   Decompensated Cirrhosis;   Hepatitis C Virus
Interventions: Drug: ABT-450/ritonavir/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
30 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection
Conditions: Chronic Hepatitis C;   Hepatitis C Virus
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin (RBV)
31 Recruiting RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: PanAd3-RSV given intra-nasally (high dose);   Biological: MVA-RSV given by intra-muscular injection (high dose);   Biological: PanAd3-RSV given by intra-muscular injection (high dose);   Biological: PanAd3-RSV given intranasally (low dose);   Biological: MVA-RSV given by intra-muscular injection (low dose);   Biological: PanAd3-RSV given by intra-muscular injection (low dose)
32 Unknown  e- Ab Sensor - Based Real-time Diagnosis of Influenza Virus
Condition: Influenza Caused by Unspecified Influenza Virus
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
33 Recruiting A Study of ALS-008176 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
34 Recruiting Virosensor -Based Real-time Diagnosis of Enterovirus 71 and Influenza Virus
Condition: Enterovirus 71 and Influenza Virus
Intervention: Device: virosensor
35 Recruiting Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression
Condition: Infections, Respiratory Syncytial Virus
Interventions: Drug: Danirixin;   Other: CXCL1
36 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 MERS-CoV;   Novel Respiratory Virus-2 SARS-CoV
Intervention:
37 Recruiting Clinical Trial of Efficacy of Anaferon for Children® in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
Condition: Influenza and Acute Respiratory Viral Infections
Interventions: Drug: Anaferon for children;   Drug: Placebo
38 Unknown  The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Conditions: Cytomegalovirus;   Epstein-Barr Virus Infections;   Herpesvirus Infection
Intervention:
39 Recruiting Medication Adherence in Human Immunodeficiency Virus (HIV)
Condition: Human Immunodeficiency Virus
Interventions: Behavioral: Staff-delivered intervention sessions;   Other: Demographic Questionnaire;   Other: Questionnaires
40 Unknown  Development of Method of Fructose Identification in Urine to Detect the Viral Infection
Condition: Human Immunodeficiency Virus
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years